<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="brief-report" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1609826</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2025.1609826</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular analysis of RAX2-regulated retinal development using human retinal organoids at a single-cell resolution</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1609826">10.3389/fcell.2025.1609826</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Shaojun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1831045/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Sun</surname>
<given-names>Yi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3028802/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Na</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1090999/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Yue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1212274/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Guang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3030841/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Senior Department of Ophthalmology</institution>, <institution>3rd Medical Center of Chinese PLA General Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>State Key Laboratory of Common Mechanism Research for Major Disease</institution>, <institution>Institute of Basic Medical Sciences</institution>, <institution>Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Medical Genetics</institution>, <institution>Institute of Basic Medical Sciences</institution>, <institution>Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Center for Regeneration, Aging and Chronic Diseases</institution>, <institution>School of Basic Medical Sciences</institution>, <institution>State Key Laboratory for Complex, Severe and Rare Diseases</institution>, <institution>Tsinghua University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/230447/overview">Debbie Guest</ext-link>, Royal Veterinary College (RVC), United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1584669/overview">Ramachandran Prakasam</ext-link>, Washington University in St. Louis, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/349862/overview">Birthe Dorgau</ext-link>, Newcastle University, United Kingdom</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yue Huang, <email>huangyue@pumc.edu.cn</email>; Guang Liu, <email>liuguang@ibms.pumc.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1609826</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Wang, Sun, Na, Huang and Liu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang, Sun, Na, Huang and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Human embryonic stem cells (hESC)-derived retinal organoids are sophisticated <italic>in vitro</italic> systems for dissecting the complex dynamics of human retinal development. The formation of the human retina is a precisely organized process that depends on the regulated differentiation of retinal progenitor cells; however, many of the basic mechanisms remain to be explored. Here, using hESC-derived retinal organoids, we elucidated the temporal contribution of RAX2 to retinal development, with an emphasis on photoreceptor cells (PC) formation. The results were corroborated using human fetal retinal tissue at various gestational ages. Using CRISPR/Cas9-mediated gene knockout, we delineated the essential role of RAX2 in modulating PC specifications. <italic>RAX2</italic> deficiency significantly altered the expression of <italic>PAX6</italic> and <italic>SOX2</italic>, two essential regulators of retinogenesis. Our results suggested that RAX2 is significant in retinal development, underpinning its potential as a therapeutic target in related retinal disorders.</p>
</abstract>
<kwd-group>
<kwd>human embryonic stem cells (hESC)</kwd>
<kwd>retinal organoid</kwd>
<kwd>retinal development</kwd>
<kwd>photoreceptor cells</kwd>
<kwd>ScRNA-seq</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Stem Cell Research</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The human retina, acting as a processor for integrating visual signals, orchestrates interactions among various retinal cell types in a delicate cellular structure. Retinogenesis is the process by which multipotent retinal progenitor cells (RPC) differentiate into specialized cells, including retinal ganglion cells (RGC), photoreceptor cells (PC, including rods and cones), M&#xfc;ller cells (MC), amacrine cells and bipolar cells. This process is meticulously orchestrated by a network of signaling pathways, as delineated in previous studies (<xref ref-type="bibr" rid="B1">Bassett and Wallace, 2012</xref>). Recent studies using bulk transcriptomic profiling, single-cell RNA sequencing (scRNA-seq), and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) have systematically examined the cellular composition and molecular expression patterns of the human retina and retinal organoids (RO) derived from human embryonic stem cells (hESC) (<xref ref-type="bibr" rid="B19">Voigt et al., 2021</xref>; <xref ref-type="bibr" rid="B10">Li et al., 2023</xref>; <xref ref-type="bibr" rid="B21">Wahle et al., 2023</xref>; <xref ref-type="bibr" rid="B27">Zhang et al., 2024</xref>). These investigations have provided critical insights into the spatiotemporal dynamics of cellular diversification, thereby offering an integrative framework for understanding the molecular mechanisms underlying retinogenesis and retinal disease pathogenesis. In a previous study, using scRNA-seq to analyze hESC derived RO at five different time points (day36-day186, D36-D186), we identified 9 cell populations, including RPC, RGC, PC, MCs, and retinal pigment epithelial (RPE) cell populations, and described the emergence, maturation, and regulation of RPC and PC populations in detail (<xref ref-type="bibr" rid="B23">Wang et al., 2021</xref>).</p>
<p>The retinal and anterior neural fold homeobox (RAX) gene family encodes homeodomain transcription factors, and is crucial for vertebrate retinal development. Through evolutionary analysis, jawed vertebrate <italic>RAX</italic> genes were classified into two distinct subgroups: <italic>RAX1</italic> (commonly referred to as <italic>RAX</italic>) and <italic>RAX2</italic> (<xref ref-type="bibr" rid="B8">Kon and Furukawa, 2020</xref>). RAX is initially expressed in the anterior neural fold and later in the embryonic diencephalon, which gives rise to the retina and pineal gland (<xref ref-type="bibr" rid="B11">Mathers et al., 1997</xref>). RAX is critical for retinal cell fate determination and the maturation and survival of PC (<xref ref-type="bibr" rid="B5">Irie et al., 2015</xref>). <italic>RAX</italic>-deficient mice exhibit severe forebrain malformations and lack optic vesicles (<xref ref-type="bibr" rid="B11">Mathers et al., 1997</xref>). Mutations in human <italic>RAX</italic> have been linked to congenital ocular disorders, including anophthalmia and microphthalmia (<xref ref-type="bibr" rid="B20">Voronina et al., 2004</xref>). RAX2 (also known as QRX) is required for retinal neurogenesis in <italic>Xenopus</italic> (<xref ref-type="bibr" rid="B25">Wu et al., 2009</xref>) and chicks (<xref ref-type="bibr" rid="B16">Sanchez-Arrones et al., 2009</xref>). Studies have found that <italic>RAX2</italic> orthologs are essential for maintaining adult medaka fish retinal stem cells (<xref ref-type="bibr" rid="B15">Reinhardt et al., 2015</xref>). RAX2 protein physically interacts with the CRX protein synergistically to modulate the expression of PC-specific genes, such as <italic>Rhodopsin</italic>. Emerging clinical evidence has linked RAX2 mutations to various inherited retinal diseases (IRD). Dominant mutations, such as c.260G&#x3e;A (p.Arg87Gln), have been associated with age-related macular degeneration (AMD), while variants like c.409G&#x3e;C (p.Gly137Arg) and c.417_422dup (p.Pro140_Gly141dup) have been linked to cone-rod dystrophy (CRD) (<xref ref-type="bibr" rid="B22">Wang et al., 2004</xref>). The heterozygous c.465_475del (p.Ala156Argfs&#x2a;131) variant, identified in familial cases of cone dystrophy or CRD, disrupts the N-terminal coding region of RAX2, potentially impairing its function as a CRX cofactor (<xref ref-type="bibr" rid="B26">Yang et al., 2015</xref>). Van de Sompele <italic>et al.</italic> demonstrated that biallelic <italic>RAX2</italic> mutations, including c.155C&#x3e;G (p.Pro52Arg), c.335dup (p.Ala113Glyfs&#x2a;178), c.145 T&#x3e;C (p.Ser49Pro), and g.3771337_3774298del, cause autosomal recessive retinitis pigmentosa (ARRP) (<xref ref-type="bibr" rid="B18">Van de Sompele et al., 2019</xref>). These mutations may impair the RAX2 protein folding, stability, and transactivation capability. Notably, RAX2 mutations are not compensated by RAX activity in human disease. Unlike humans, mice lack <italic>RAX2</italic> orthologue, complicating functional studies (<xref ref-type="bibr" rid="B22">Wang et al., 2004</xref>). ScRNA-seq analysis of the human fetal neural retina revealed that RAX2 was primarily expressed in PC (<xref ref-type="bibr" rid="B4">Hu et al., 2019</xref>), which aroused our interest in exploring its potential role in human retinogenesis.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Patients and tissue samples</title>
<p>The five human retinal specimens used in this study were obtained from voluntarily donated aborted fetuses, sourced from the Senior Department of Ophthalmology at the Third Medical Center of the Chinese PLA General Hospital. The Ethics Committee of the Third Medical Center of the Chinese PLA General Hospital approved this study (ID: KY 2021-021), and written informed consent was obtained from all participants. The procedures in this study adhered to the Helsinki Declaration of 1964 and its amendments, ensuring ethical integrity (<xref ref-type="bibr" rid="B24">World Medical, 2013</xref>).</p>
</sec>
<sec id="s2-2">
<title>2.2 hESC culture and RO differentiation</title>
<p>The hESC line H9 were routinely cultured in Essential 8 medium (ThermoFisher, A1517001) on plates coated with Vitronectin (Gibco, A14700). For passaging, cells were treated with Accutase (Stemcell Tech, 07920). RO differentiation followed established protocols with minor modifications (<xref ref-type="bibr" rid="B23">Wang et al., 2021</xref>; <xref ref-type="bibr" rid="B9">Kuwahara et al., 2015</xref>). Aggregates were cultured under 40% O<sub>2</sub>/5% CO<sub>2</sub> conditions (30 aggregates per 10-cm dish) from day 24 (D24), using an NR-differentiation medium comprising DMEM/F12 (Gibco, 10565018), KSR (Gibco, 10828028), N2 supplement (Gibco, A1370701), 0.1 mM taurine (Sigma, T0625), and 0.5 &#x3bc;M retinoic acid (Sigma, R2625). Under these conditions, RO continued to grow for several weeks.</p>
</sec>
<sec id="s2-3">
<title>2.3 Establishment of genetically engineered hESC</title>
<p>Single guide RNAs (sgRNA) constructs targeting critical <italic>RAX2</italic> were cloned into px459 plasmids (Addgene, 62988) for knockout cell generation. HESC were transfected with these sgRNA plasmids using the Lipofectamine Stem Transfection Reagent (Invitrogen, STEM00001) and exposed to 0.5 &#x3bc;g/mL puromycin for 48 h 2,000&#x2013;3,000 surviving cells were plated on a 6 cm dish, and 96 single colonies were picked up to a 96-well plate. Genomic DNA was extracted for PCR using specific primers:</p>
<p>Fw: CTTAGGGCGTGAGAAGGGAT;</p>
<p>Rv: CCCCACGCCCAATTAACAGA.</p>
<p>The PCR products were validated by TA cloning and Sanger sequencing to confirm <italic>RAX2</italic> gene deletions.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Highly-expressed RAX2 in PC within RO and human fetal retinal tissue</title>
<p>Our earlier investigation used an <italic>in vitro</italic> self-organization model of human RO derived from hESC, which mimicked human retinal development, to conduct an scRNA-seq analysis at five different time points during RO differentiation (D36, D66, D96, D126, and D186) (<xref ref-type="bibr" rid="B23">Wang et al., 2021</xref>). In this study, to delineate the role of the RAX2 in retinogenesis, we reanalyzed the scRNA-seq data. Canonical markers were used to distinguish 6 cell clusters: RPC, Proliferating-RPC, PC, RGC, MCs and RPE cells (<xref ref-type="sec" rid="s12">Supplementary Figures S1A, S1B</xref>). RAX2 was primarily detected in the PC population (<xref ref-type="fig" rid="F1">Figure 1A</xref>). A gradual increase in <italic>RAX2</italic> expression correlating with PC emergence in RO was observed (<xref ref-type="fig" rid="F1">Figures 1B&#x2013;D</xref>), consistent with the immunofluorescence (IF) staining of human RO, which also revealed a progressive increase in RAX2-positive cells (<xref ref-type="fig" rid="F1">Figure 1E</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S2A</xref>). Moreover, <italic>RAX2</italic> expression patterns aligned with canonical PC markers, including <italic>CRX</italic>, <italic>NR2E3</italic> and <italic>NRL</italic> (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). CRX-positive cells appeared at D36 in a human RO culture and gradually increased over time. The expression of <italic>NRL</italic> and <italic>NR2E3</italic> significantly increased during the maturation of PC (<xref ref-type="bibr" rid="B23">Wang et al., 2021</xref>), and <italic>OTX2</italic> was found to be involved in embryonic PC fate determination (<xref ref-type="bibr" rid="B12">Muranishi et al., 2011</xref>). To enhance our comprehension of RAX2 dynamics in retinal development, we obtained human retinal tissue from voluntarily donated aborted fetuses aged 12&#x2013;24 weeks of gestation, and performed multi-immunofluorescence (multi-IF) staining to precisely track the temporal expression patterns of RAX2 (<xref ref-type="fig" rid="F1">Figure 1F</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S2B</xref>). A notable increase in RAX2-positive cells was observed from 20 to 24 weeks, coinciding with the reported initiation of PC development (<xref ref-type="bibr" rid="B4">Hu et al., 2019</xref>). These findings indicated that RAX2 may regulate PC maturation during retinal development.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Highly expressed <italic>RAX2</italic> in PC during early stages of RO and tissue. <bold>(A)</bold> Multiple feature plots of RO display integrated expression profiles across five timepoints (D036, D066, D096, D126, D186), highlighting the expression of <italic>RAX2</italic> and the hallmark genes of the PC population, including <italic>CRX</italic>, <italic>NRL</italic> and <italic>NR2E3</italic>, in hESC-derived RO. <bold>(B)</bold> Pseudotemporal trajectory map exhibiting the expression of <italic>RAX2</italic> and marker genes of PC population, including <italic>CRX</italic>, <italic>NRL</italic>, and <italic>NR2E3</italic> in hESC-derived RO at different timepoints (D036, D066, D096, D126, D186). <bold>(C)</bold> Multiple feature plots exhibiting <italic>RAX2</italic> expression in hESC-derived RO at different timepoints (D036, D066, D096, D126, D186). <bold>(D)</bold> Violin plots exhibiting <italic>RAX2</italic> gene expression in hESC-derived RO at different timepoints (D036, D066, D096, D126, D186). <bold>(E)</bold> Representative IF-staining images of CRX and RAX2 in hESC-derived RO at different timepoints (D036, D096, D126). Scale bars, 40 &#x3bc;m. <bold>(F)</bold> Representative IF-staining images of RAX2 and OTX2 in human retinal tissue from aborted fetuses, spanning gestational ages of 12&#x2013;24 weeks. Scale bars, 40 &#x3bc;m. W: weeks.</p>
</caption>
<graphic xlink:href="fcell-13-1609826-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Establishment of <italic>RAX2</italic>-knockout hESC utilizing CRISPR/Cas9-mediated gene editing</title>
<p>To explore the influence of RAX2 on human retinal development, the CRISPR/Cas9 system was used to disrupt critical exons of <italic>RAX2</italic> in hESC (H9 cell line). Seven sgRNAs were created to target different regions around the gene, and their effectiveness was evaluated using a surveyor assay (<xref ref-type="sec" rid="s12">Supplementary Figure S3</xref>). Cas9/sgRNA-7 and Cas9/sgRNA-6, both of which exhibited notable cleavage efficiencies, were selected for subsequent gene editing (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Two homozygous mutants, <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup>-1 and <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup>-2, were successfully generated and validated through Sanger sequencing (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Evaluation of genomic copy number variation (CNV) (<xref ref-type="sec" rid="s12">Supplementary Figure S4</xref>), ESC colony morphology (<xref ref-type="fig" rid="F2">Figure 2C</xref>), pluripotency markers expression (<xref ref-type="fig" rid="F2">Figure 2D</xref>), and cell proliferation (<xref ref-type="fig" rid="F2">Figure 2E</xref>) showed no significant differences between <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and wild type (WT) hESC. Embryoid body (EB) formation assay (<xref ref-type="fig" rid="F2">Figures 2F,G</xref>) revealed that RAX2 deficiency in hESC significantly reduced the expression of ectoderm markers in the derived EBs, including <italic>MAP2</italic>, <italic>PAX6</italic>, <italic>RAX</italic>, and <italic>SIX6</italic> (<xref ref-type="fig" rid="F2">Figure 2H</xref>). This finding underscored the essential function of <italic>RAX2</italic> in the ectoderm-related differentiation process.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Establishment of <italic>RAX2</italic>-knockout hESC. <bold>(A)</bold> Schematic illustration of knocking out <italic>RAX2</italic> in hESC by CRISPR/Cas9 system. Scissors indicate the sgRNAs; boxes represent the exons; triangular arrows represent primers. Fw: forward primer; Rv: reverse primer. <bold>(B)</bold> Sanger sequencing results for <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC clones. Red words indicate the PAM sequence; ellipses in parentheses indicate sequences that are not listed; dashed line indicates deleted bases. <bold>(C)</bold> Alkaline phosphatase staining of <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC clones. Scale bars, 100 &#x3bc;m. <bold>(D)</bold> Representative IF-staining images of pluripotency markers in <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC clones. Scale bars, 100 &#x3bc;m. <bold>(E)</bold> Cell proliferation rate of <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC clones (n &#x3d; 3 independent experiments). ns, not significantly different. <bold>(F)</bold> Representative images of EB formation assay for <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC clones. Scale bar, 200 &#x3bc;m. <bold>(G)</bold> RT-qPCR analysis for <italic>POU5F1</italic> and <italic>NANOG</italic> expression in <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC -derived EBs at different timepoints (D0, D6, D12). <bold>(H)</bold> RT-qPCR analysis for ectoderm, endoderm, and mesoderm markers expression in <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC -derived EBs at different timepoints (D0, D6, D12).</p>
</caption>
<graphic xlink:href="fcell-13-1609826-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 <italic>RAX2</italic> deficiency affects PC fate determination during RO differentiation</title>
<p>Using a previously established BMP4-induced RO self-organization protocol (<xref ref-type="bibr" rid="B23">Wang et al., 2021</xref>), WT and <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> hESC were grown in a 3D culture for 66 days (<xref ref-type="fig" rid="F3">Figure 3A</xref>), and twenty-four RO were harvested for scRNA-seq analysis from each of WT and RAX2<sup>&#x2212;/&#x2212;</sup> group. Following a rigorous quality control evaluation and removal of doublets, a UMAP analysis revealed five primary cell clusters, with the cell types identified through enriched gene profiles and canonical markers (<xref ref-type="fig" rid="F3">Figures 3B,C</xref>). A marked reduction in <italic>RAX2</italic> expression was detected in all the <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> hESC-derived RO cell clusters identified (<xref ref-type="fig" rid="F3">Figure 3D</xref>). A significant decrease in the percentage of PC, RPC, and RPE cell populations was observed in RO derived from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> hESC compared to the those from WT hESC (<xref ref-type="fig" rid="F3">Figure 3E</xref>). Considering the process of retinal development, we focused on RPC, RGC, and PC clusters (<xref ref-type="fig" rid="F3">Figures 3F,G</xref>). A developmental pseudotime trajectory analysis was conducted, which helped reveal highly interconnected nodes potentially indicating the differentiation status (<xref ref-type="fig" rid="F3">Figures 3H,I</xref>). Depletion of <italic>RAX2</italic> significantly altered various cellular distributions. Differentiation into PC was notably affected by the absence of <italic>RAX2</italic>, leading to a bias towards RGC lineage commitment. Additionally, the PC population analysis revealed a decrease in pathways associated with PC differentiation (<xref ref-type="fig" rid="F3">Figure 3J</xref>). RT-qPCR analysis demonstrated decreased expression of PC-specific markers (<italic>CRX</italic>, <italic>NRL</italic>, and <italic>NR2E3</italic>) in RO derived from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> hESC, alongside elevated levels of RGC markers (<italic>POU4F2</italic> and <italic>THY1</italic>), consistent with the observed lineage bias (<xref ref-type="sec" rid="s12">Supplementary Figure S5</xref>). These findings underscored the critical function of RAX2 in PC fate determination.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The absence of <italic>RAX2</italic> affects PC fate determination. <bold>(A)</bold> Representative images of <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived human RO at D36 and D66. Scale bars, 100 &#x3bc;m. <bold>(B)</bold> UMAP plots of the <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO in D66, labeled by cell types. <bold>(C)</bold> Dot plots for the marker genes expression by cell types. The color represents the average expression level; the size of dot represents the percentage of cells within a cell type. <bold>(D)</bold> Violin plots for <italic>RAX2</italic> expression in clusters from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO. <bold>(E)</bold> Proportion of each cell types from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO in D66. <bold>(F)</bold> UMAP plot of the RPC, PC and RGC clusters from the <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO in D66, labeled by cell types. <bold>(G)</bold> Percentages of the RPC, PC and RGC clusters from the <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO in D66. <bold>(H)</bold> The Monocle 2 trajectory plot showing the pseudotemporal ordering of cluster RPC, RGC and PC from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO in D66. Numbers in black circles indicate the different cell status numbers. <bold>(I)</bold> Pseudotemporal ordering trajectory map of RPC, RGC and PC clusters from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO in D66. The colors from dark to light indicate the pseudotime order. <bold>(J)</bold> GO analysis of the top 10 downregulated biological processes in PC subset from the <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO at D66. Horizontal axis values the count of enriched genes per term.</p>
</caption>
<graphic xlink:href="fcell-13-1609826-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 RAX2 regulates the expression of <italic>PAX6</italic> and <italic>SOX2</italic> during RO differentiation</title>
<p>In our previous study, we observed that the proportion of each cell type, including PC, in <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> hESC-derived RO differed from that of the WT RO (<xref ref-type="fig" rid="F3">Figure 3E</xref>), suggesting that RAX2 influenced the differentiation state of the entire organoid. To elucidate the underlying mechanism, we analyzed differentially expressed genes and noticed that the expression patterns of <italic>PAX6</italic> (<xref ref-type="bibr" rid="B13">Oron-Karni et al., 2008</xref>) and <italic>SOX2</italic> (<xref ref-type="bibr" rid="B3">Diacou et al., 2022</xref>), both vital for eye development, were significantly altered by <italic>RAX2</italic> deficiency (<xref ref-type="fig" rid="F4">Figure 4A</xref>). RT-qPCR and Western blot analyses confirmed the reduced expression of PAX6 and SOX2 (<xref ref-type="fig" rid="F4">Figures 4B,C</xref>). In addition, IF staining analysis of human RO at D66 revealed a marked decrease in the fluorescence intensity of PAX6 and SOX2 in <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> hESC-derived RO (<xref ref-type="fig" rid="F4">Figure 4D</xref>). Overall, our results suggested that RAX2 is critical for retinal development by modulating <italic>PAX6</italic> and <italic>SOX2</italic> expression.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>RAX2 regulates <italic>PAX6</italic> and <italic>SOX2</italic> expression. <bold>(A)</bold> Expression of <italic>SOX2</italic> and <italic>PAX6</italic> from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC-derived RO over pseudotime. <bold>(B)</bold> RT-qPCR analysis for the expression of <italic>RAX2</italic>, <italic>PAX6</italic>, and <italic>SOX2</italic> in RO derived from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC at D66. All experiments were repeated in three batches of organoids. <bold>(C)</bold> Expression of PAX6, and SOX2 in RO derived from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC at D66 was detected by Western blot. All experiments were repeated in three batches of organoids. <bold>(D)</bold> Representative images of IF staining of RAX2, PAX6, and SOX2 in RO derived from <italic>RAX2</italic>
<sup>&#x2212;/&#x2212;</sup> and WT hESC at D66. Scale bars, 40 &#x3bc;m. All experiments were repeated in three batches of organoids.</p>
</caption>
<graphic xlink:href="fcell-13-1609826-g004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>In this work, we systematically examined the expression patterns of <italic>RAX2</italic> in human fetal retinal tissue and hESC-derived RO at different stages. By integrating bioinformatics analyses with biochemical assays of RNA and protein levels in <italic>RAX2</italic>-deficient hESC-derived RO, we delineated RAX2 as a pivotal determinant of PC specification. Notably, the loss of RAX2 significantly altered the proportions of various cell populations within the RO. The scRNA-seq results, validated through RT-qPCR, Western blotting, and IF staining, demonstrated that these alterations correlated with reduced expression of PAX6 and SOX2, which are key regulators in retinal development. The precise modulation of <italic>PAX6</italic> and <italic>SOX2</italic> expression within optic cup progenitors is essential for retina development, with a release of neural potential in the retina (<xref ref-type="bibr" rid="B6">Klimova and Kozmik, 2014</xref>; <xref ref-type="bibr" rid="B13">Oron-Karni et al., 2008</xref>). The spatial and temporal regulation of PAX6 expression, however, remains incompletely understood, suggesting that the regulatory function of RAX2 may be more complex than previously appreciated (<xref ref-type="bibr" rid="B22">Wang et al., 2004</xref>).</p>
<p>Our observations suggest that alterations in RAX2 expression are vital for retinal development, particularly in PC. Previous researches have shown the specific co-expression patterns of Rax2 and Vsx2 in defining retinal cell identity (<xref ref-type="bibr" rid="B14">Pandit et al., 2015</xref>), with external signals like BMP activity influencing RAX2 expression in chicks and zebrafish (<xref ref-type="bibr" rid="B2">Bielen and Houart, 2012</xref>). In the human retina, RAX2 is present in the outer and inner nuclear layers and serves as a PCE-1-binding protein, partnering with CRX and NRL to manage the expression of photoreceptor genes (<xref ref-type="bibr" rid="B22">Wang et al., 2004</xref>). Given the complex interplay among retinal cells and minor deviations may disrupt homeostasis, the deletion of <italic>RAX2</italic> could create cascading effects on retinal cell viability, thus affecting the progression of retinal development.</p>
<p>Our findings have significant translational relevance due to their potential for supporting retinal diseases treatments involving photoreceptor loss, such as retinitis pigmentosa (<xref ref-type="bibr" rid="B7">Klymenko et al., 2024</xref>) and AMD (<xref ref-type="bibr" rid="B17">Tan et al., 2023</xref>). RAX2 expression modulation may provide dual effects of both preventing photoreceptor degeneration and promoting their regeneration. Future studies should investigate the role of RAX2 in ocular development, develop therapies by expressing the human <italic>RAX2</italic> gene in Rax-deficient mice, and generate disease models using RO. Understanding RAX2&#x2019;s interactions with key developmental genes like <italic>PAX6</italic> and <italic>SOX2</italic> is crucial for advancing gene therapy approaches for retinal disorders.</p>
<p>Our study acknowledges limitations in fully delineating the molecular interactions of RAX2. Future research using advanced genetic techniques and precise temporal analysis will be essential for elucidating the detailed mechanisms underlying this genetic pathway in retinal development. This study highlights the importance of further exploring the regulatory functions and interactions of RAX2 to improve our comprehension of retinal development and discover new therapeutic interventions for retinal disorders linked to these cells.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Ethics Committee of the Third Medical Center of the Chinese PLA General Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>SW: Investigation, Conceptualization, Data curation, Funding acquisition, Writing &#x2013; original draft. YS: Investigation, Writing &#x2013; original draft, Data curation. JN: Methodology, Resources, Writing &#x2013; original draft. YH: Writing &#x2013; review and editing, Project administration, Funding acquisition. GL: Project administration, Resources, Conceptualization, Funding acquisition, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the CAMS Innovation Fund for Medical Sciences (CIFMS, 2021-I2M-1-024 to GL), Beijing Natural Science Foundation (7242176 to SW; 5232024 to GL), the National Natural Science Foundation of China (31970813 to YH), and the State Key Laboratory Special Fund (2060204).</p>
</sec>
<ack>
<p>We thank State Key Laboratory of Common Mechanism Research of Major Diseases Platform and Center for Experimental Animal Research (IBMS, CAMS) for consultation and instrument availability that supported this work. We thank LetPub (<ext-link ext-link-type="uri" xlink:href="http://www.letpub.com.cn">www.letpub.com.cn</ext-link>) for its linguistic assistance during the preparation of this manuscript.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2025.1609826/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2025.1609826/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassett</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Cell fate determination in the vertebrate retina</article-title>. <source>Trends Neurosci.</source> <volume>35</volume>, <fpage>565</fpage>&#x2013;<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.05.004</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bielen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Houart</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>BMP signaling protects telencephalic fate by repressing eye identity and its Cxcr4-dependent morphogenesis</article-title>. <source>Dev. Cell</source> <volume>23</volume>, <fpage>812</fpage>&#x2013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.09.006</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diacou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nandigrami</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fiser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ashery-Padan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Cell fate decisions, transcription factors and signaling during early retinal development</article-title>. <source>Prog. Retin Eye Res.</source> <volume>91</volume>, <fpage>101093</fpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2022.101093</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Dissecting the transcriptome landscape of the human fetal neural retina and retinal pigment epithelium by single-cell RNA-seq analysis</article-title>. <source>PLoS Biol.</source> <volume>17</volume>, <fpage>e3000365</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3000365</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sanuki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Muranishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chaya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Rax homeoprotein regulates photoreceptor cell maturation and survival in association with crx in the postnatal mouse retina</article-title>. <source>Mol. Cell Biol.</source> <volume>35</volume>, <fpage>2583</fpage>&#x2013;<lpage>2596</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00048-15</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klimova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kozmik</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Stage-dependent requirement of neuroretinal Pax6 for lens and retina development</article-title>. <source>Development</source> <volume>141</volume>, <fpage>1292</fpage>&#x2013;<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1242/dev.098822</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klymenko</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gonz&#xe1;LEZ Mart&#xed;NEZ</surname>
<given-names>O. G.</given-names>
</name>
<name>
<surname>Zarbin</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Recent progress in photoreceptor cell-based therapy for degenerative retinal disease</article-title>. <source>Stem Cells Transl. Med.</source> <volume>13</volume>, <fpage>332</fpage>&#x2013;<lpage>345</lpage>. <comment>szae005</comment>. <pub-id pub-id-type="doi">10.1093/stcltm/szae005</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Origin and evolution of the Rax homeobox gene by comprehensive evolutionary analysis</article-title>. <source>FEBS Open Bio</source> <volume>10</volume>, <fpage>657</fpage>&#x2013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1002/2211-5463.12832</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwahara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozone</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Eiraku</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sasai</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue</article-title>. <source>Nat. Commun.</source> <volume>6</volume>, <fpage>6286</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms7286</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Integrative single-cell transcriptomics and epigenomics mapping of the fetal retina developmental dynamics</article-title>. <source>Adv. Sci. (Weinh)</source> <volume>10</volume>, <fpage>e2206623</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202206623</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathers</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Grinberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahon</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Jamrich</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The Rx homeobox gene is essential for vertebrate eye development</article-title>. <source>Nature</source> <volume>387</volume>, <fpage>603</fpage>&#x2013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1038/42475</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muranishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Terada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Katoh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsujii</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sanuki</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>An essential role for RAX homeoprotein and NOTCH-HES signaling in Otx2 expression in embryonic retinal photoreceptor cell fate determination</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>16792</fpage>&#x2013;<lpage>16807</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3109-11.2011</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oron-Karni</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Farhy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Elgart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marquardt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Remizova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yaron</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Dual requirement for Pax6 in retinal progenitor cells</article-title>. <source>Development</source> <volume>135</volume>, <fpage>4037</fpage>&#x2013;<lpage>4047</lpage>. <pub-id pub-id-type="doi">10.1242/dev.028308</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandit</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jidigam</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Patthey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gunhaga</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Neural retina identity is specified by lens-derived BMP signals</article-title>. <source>Development</source> <volume>142</volume>, <fpage>1850</fpage>&#x2013;<lpage>1859</lpage>. <pub-id pub-id-type="doi">10.1242/dev.123653</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinhardt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Centanin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tavhelidse</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wittbrodt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Concordet</surname>
<given-names>J. P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Sox2, Tlx, Gli3, and Her9 converge on Rx2 to define retinal stem cells <italic>in vivo</italic>
</article-title>. <source>EMBO J.</source> <volume>34</volume>, <fpage>1572</fpage>&#x2013;<lpage>1588</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201490706</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez-Arrones</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ferran</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Rodriguez-Gallardo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Puelles</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Incipient forebrain boundaries traced by differential gene expression and fate mapping in the chick neural plate</article-title>. <source>Dev. Biol.</source> <volume>335</volume>, <fpage>43</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2009.08.012</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Single-cell RNA sequencing in dissecting microenvironment of age-related macular degeneration: challenges and perspectives</article-title>. <source>Ageing Res. Rev.</source> <volume>90</volume>, <fpage>102030</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2023.102030</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>VAN De Sompele</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Karali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Corton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>VAN Schil</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Peelman</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Biallelic sequence and structural variants in RAX2 are a novel cause for autosomal recessive inherited retinal disease</article-title>. <source>Genet. Med.</source> <volume>21</volume>, <fpage>1319</fpage>&#x2013;<lpage>1329</lpage>. <pub-id pub-id-type="doi">10.1038/s41436-018-0345-5</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voigt</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Mullin</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Scheetz</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Mullins</surname>
<given-names>R. F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Single-cell RNA sequencing in vision research: insights into human retinal health and disease</article-title>. <source>Prog. Retin Eye Res.</source> <volume>83</volume>, <fpage>100934</fpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2020.100934</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voronina</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Kozhemyakina</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>O&#x27;Kernick</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Wenger</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Linberg</surname>
<given-names>J. V.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Mutations in the human RAX homeobox gene in a patient with anophthalmia and sclerocornea</article-title>. <source>Hum. Mol. Genet.</source> <volume>13</volume>, <fpage>315</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh025</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brancati</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Harmel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gut</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Del Castillo</surname>
<given-names>J. S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Multimodal spatiotemporal phenotyping of human retinal organoid development</article-title>. <source>Nat. Biotechnol.</source> <volume>41</volume>, <fpage>1765</fpage>&#x2013;<lpage>1775</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-023-01747-2</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Esumi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Swain</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>QRX, a novel homeobox gene, modulates photoreceptor gene expression</article-title>. <source>Hum. Mol. Genet.</source> <volume>13</volume>, <fpage>1025</fpage>&#x2013;<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh117</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Poli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Longitudinal single-cell RNA-seq of hESCs-derived retinal organoids</article-title>. <source>Sci. China Life Sci.</source> <volume>64</volume>, <fpage>1661</fpage>&#x2013;<lpage>1676</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-020-1836-7</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>World Medical</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects</article-title>. <source>JAMA</source> <volume>310</volume>, <fpage>2191</fpage>&#x2013;<lpage>2194</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2013.281053</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Perron</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hollemann</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The role of Xenopus Rx-L in photoreceptor cell determination</article-title>. <source>Dev. Biol.</source> <volume>327</volume>, <fpage>352</fpage>&#x2013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2008.12.017</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Weleber</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Pennesi</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Autosomal dominant retinal dystrophy with electronegative waveform associated with a novel RAX2 mutation</article-title>. <source>JAMA Ophthalmol.</source> <volume>133</volume>, <fpage>653</fpage>&#x2013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2015.0357</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Simultaneous profiling of RNA isoforms and chromatin accessibility of single cells of human retinal organoids</article-title>. <source>Nat. Commun.</source> <volume>15</volume>, <fpage>8022</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-52335-0</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>